Release Date: 27/02/09 10:41 Summary: Half Yearly Report and Accounts Price Sensitive: Yes Download Document 1.15MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%